Review of pyronaridine anti-malarial properties and product characteristics

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Croft, Simon L ^a   Duparc, Stephan ^b   Arbe Barnes, Sarah J ^c   Craft, J Carl ^d   Shin, Chang Sik ^e   Fleckenstein, Lawrence ^f   Borghini Fuhrer, Isabelle ^b   Rim, Han Jong ^g  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Medicines for Malaria Venture   (Switzerland)

^c ICON PLC   (United Kingdom)

^d Former MMV Chief Scientific Officer   (United States)

^e Shin Poong Pharmaceuticals Co Ltd   (South Korea)

^f UNIVERSITY OF IOWA   (United States)

^g Korea University College of Medicine   (South Korea)

Author keywords

Anti malarial therapy; Artemisinin containing compound; Plasmodium falciparum; Plasmodium vivax; Pyronaridine; Review

Indexed keywords

2,4 DIAMINO 6 (3,4 DICHLOROBENZYLNITROSAMINO)QUINAZOLINE; ALANINE AMINOTRANSFERASE; AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; ARTESUNATE PLUS PYRONARIDINE; ASPARTATE AMINOTRANSFERASE; CHLOROQUINE; DIHYDROARTEMISININ; MEFLOQUINE; MEPACRINE; PIPERAQUINE; PRIMAQUINE; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; PYRONARIDINE; QUININE; SULFADOXINE;

ABDOMINAL DISCOMFORT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; AREA UNDER THE CURVE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BRADYCARDIA; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CONVULSION; CYTOTOXICITY; DIARRHEA; DIZZINESS; DRUG ELIMINATION; DRUG HALF LIFE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EMBRYOTOXICITY; EOSINOPHIL COUNT; ERYTHEMA; EXPERIMENTAL MODEL; FATIGUE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HEART VENTRICLE FIBRILLATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPEREMIA; HYPERPLASIA; HYPERTROPHY; INJECTION SITE IRRITATION; INJECTION SITE REACTION; LEUKOCYTE COUNT; LIVER TOXICITY; LYMPHOCYTE COUNT; MALARIA; MALARIA FALCIPARUM; MAXIMUM PLASMA CONCENTRATION; METABOLISM; MONOTHERAPY; MORTALITY; MUTAGENICITY; MYALGIA; NAUSEA; NEUTROPHIL COUNT; NONHUMAN; PARASITE CLEARANCE; PARASITEMIA; PHOTOTOXICITY; PLASMODIUM CHABAUDI INFECTION; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE INFECTION; PLASMODIUM OVALE MALARIA; PLASMODIUM VIVAX MALARIA; PREGNANCY; PRURITUS; RETICULOCYTE; REVIEW; SIDE EFFECT; SKIN ALLERGY; SWELLING; TACHYCARDIA; THROMBOCYTE; TIME TO MAXIMUM PLASMA CONCENTRATION; TREMOR; UNSPECIFIED SIDE EFFECT; UREA BLOOD LEVEL; VOMITING; WEIGHT GAIN;

ANTIMALARIALS; CHINA; DRUG THERAPY, COMBINATION; DRUG TOXICITY; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; NAPHTHYRIDINES; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; TREATMENT OUTCOME;

EID: 84864685075     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-270     Document Type: Review

References (128)

1. Synthesis of new antimalarial drug pyronaridine and its analogues (author's transl). Zheng XY, Chen C, Gao FH, Zhu PE, Guo HZ, Yao Xue Xue Bao 1982 17 118 125 7102320
2. Synthesis of 7351, a new antimalarial drug (author's transl). Zheng XY, Xia Y, Gao FH, Chen C, Yao Xue Xue Bao 1979 14 736 737 554435
3. Studies on a new antimalarial compound: pyronaridine. Chang C, Lin-Hua T, Jantanavivat C, Trans R Soc Trop Med Hyg 1992 86 7 10 10.1016/0035-9203(92) 90414-8 1566313
4. Improved assay method for the determination of pyronaridine in plasma and whole blood by high-performance liquid chromatography for application to clinical pharmacokinetic studies. Chen YC, Fleckenstein L, J Chromatogr B Biomed Sci Appl 2001 752 39 46 10.1016/S0378-4347(00)00512-0 11254195 (Pubitemid 32141190)
5. A review of antimalarial drug pyronaridine. Shao BR, Chin Med J (Engl) 1990 103 428 434
6. A new and simple solid-phase extraction method for LC determination of pyronaridine in human plasma. Ramanathan S, Karupiah S, Nair NK, Olliaro PL, Navaratnam V, Wernsdorfer WH, Mansor SM, J Chromatogr B Analyt Technol Biomed Life Sci 2005 824 45 50 10.1016/j.jchromb.2005.06.034 16046285 (Pubitemid 41215580)
7. Determination of the physicochemical properties of pyronaridine-a new antimalarial drug. Adegoke OA, Babalola CP, Oshitade OS, Famuyiwa AA, Pak J Pharm Sci 2006 19 1 6 16632444
8. Effect of disposition of mannich antimalarial agents on their pharmacology and toxicology. Ruscoe JE, Tingle MD, O'Neill PM, Ward SA, Park BK, Antimicrob Agents Chemother 1998 42 2410 2416 9736572 (Pubitemid 28420387)
9. In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum. Childs GE, Hausler B, Milhous W, Chen C, Wimonwattrawatee T, Pooyindee N, Boudreau EF, Am J Trop Med Hyg 1988 38 24 29 3277460 (Pubitemid 18036107)
10. In vitro activity of pyronaridine against African strains of Plasmodium falciparum. Basco LK, Le Bras J, Ann Trop Med Parasitol 1992 86 447 454 1288425 (Pubitemid 23040784)
11. Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo. Vivas L, Rattray L, Stewart L, Bongard E, Robinson B, Peters W, Croft SL, Acta Trop 2008 105 222 228 10.1016/j.actatropica.2007.12.005 18279817
12. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. Basco LK, Le Bras J, Ann Trop Med Parasitol 1994 88 137 144 8067809 (Pubitemid 24201897)
13. In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum. Alin MH, Bjorkman A, Ashton M, Trans R Soc Trop Med Hyg 1990 84 635 637 10.1016/0035-9203(90)90129-3 2278058 (Pubitemid 20358567)
14. In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine. Pradines B, Mabika Mamfoumbi M, Parzy D, Owono Medang M, Lebeau C, Mourou Mbina JR, Doury JC, Kombila M, Am J Trop Med Hyg 1999 60 105 108 9988332 (Pubitemid 29066013)
15. In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs. Pradines B, Tall A, Fusai T, Spiegel A, Hienne R, Rogier C, Trape JF, Le Bras J, Parzy D, Antimicrob Agents Chemother 1999 43 418 420 9925550 (Pubitemid 29079190)
16. In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents. Pradines B, Tall A, Parzy D, Spiegel A, Fusai T, Hienne R, Trape JF, Doury JC, J Antimicrob Chemother 1998 42 333 339 10.1093/jac/42.3.333 9786473 (Pubitemid 28442447)
17. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Ringwald P, Bickii J, Basco LK, Am J Trop Med Hyg 1996 55 254 258 8842110 (Pubitemid 26321827)
18. Morphological effects of pyronaridine on malarial parasites. Wu LJ, Rabbege JR, Nagasawa H, Jacobs G, Aikawa M, Am J Trop Med Hyg 1988 38 30 36 3277462
19. Targeting of hematin by the antimalarial pyronaridine. Auparakkitanon S, Chapoomram S, Kuaha K, Chirachariyavej T, Wilairat P, Antimicrob Agents Chemother 2006 50 2197 2200 10.1128/AAC.00119-06 16723583 (Pubitemid 43807543)
20. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Dorn A, Vippagunta SR, Matile H, Jaquet C, Vennerstrom JL, Ridley RG, Biochem Pharmacol 1998 55 727 736 10.1016/S0006-2952(97)00510-8 9586944 (Pubitemid 28319636)
21. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs. Famin O, Krugliak M, Ginsburg H, Biochem Pharmacol 1999 58 59 68 10.1016/S0006-2952(99)00059-3 10403519 (Pubitemid 29246074)
22. Plasmodium falciparum: in vitro interactions of artemisinin with amodiaquine, pyronaridine, and chloroquine. Gupta S, Thapar MM, Mariga ST, Wernsdorfer WH, Bjorkman A, Exp Parasitol 2002 100 28 35 10.1006/expr.2001.4659 11971651 (Pubitemid 36268618)
23. In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs. Davis TM, Hamzah J, Ilett KF, Karunajeewa HA, Reeder JC, Batty KT, Hackett S, Barrett PH, Antimicrob Agents Chemother 2006 50 2883 2885 10.1128/AAC.00177-06 16870794 (Pubitemid 44198722)
24. In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum. Ringwald P, Eboumbou EC, Bickii J, Basco LK, Antimicrob Agents Chemother 1999 43 1525 1527 10348789 (Pubitemid 29259362)
25. [Ultrastructural study on the effect of pyronaridine on the erythrocytic stages of chloroquine-resistant strain of Plasmodium berghei](in Chinese). Wu LJ, Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1986 4 263 266 3552291
26. [Effect of pyronaridine on ultrastructure of erythrocytic forms of Plasmodium berghei in mice] (in Chinese). Wu LJ, Zhongguo Yao Li Xue Bao 1985 6 280 283 2945375 (Pubitemid 16227816)
27. The effects of pyronaridine on the morphology of Plasmodium falciparum in Aotus trivirgatus. Kawai S, Kano S, Chang C, Suzuki M, Am J Trop Med Hyg 1996 55 223 229 8780465 (Pubitemid 26299211)
28. Antimalarial 9-anilinoacridine compounds directed at hematin. Auparakkitanon S, Noonpakdee W, Ralph RK, Denny WA, Wilairat P, Antimicrob Agents Chemother 2003 47 3708 3712 10.1128/AAC.47.12.3708-3712.2003 14638470 (Pubitemid 37484976)
29. Antimalarial activity of concanamycin A alone and in combination with pyronaridine. Auparakkitanon S, Wilairat P, Southeast Asian J Trop Med Public Health 2006 37 619 621 17121284 (Pubitemid 44606548)
30. Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro. Chavalitshewinkoon P, Wilairat P, Gamage S, Denny W, Figgitt D, Ralph R, Antimicrob Agents Chemother 1993 37 403 406 10.1128/AAC.37.3.403 8384810 (Pubitemid 23072580)
31. Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum. Auparakkitanon S, Wilairat P, Biochem Biophys Res Commun 2000 269 406 409 10.1006/bbrc.2000.2305 10708566 (Pubitemid 30440313)
32. Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro. Elueze EI, Croft SL, Warhurst DC, J Antimicrob Chemother 1996 37 511 518 10.1093/jac/37.3.511 9182108 (Pubitemid 26116966)
33. [Sensitivities of different stages of erythrocytic Plasmodium falciparum to pyronaridine](in Chinese). Chen KY, Ha SH, Zhan CQ, Shao BR, Zhongguo Yao Li Xue Bao 1987 8 348 351 3328464
34. New quinoline di-Mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine, or pyronaridine. Kotecka BM, Barlin GB, Edstein MD, Rieckmann KH, Antimicrob Agents Chemother 1997 41 1369 1374 9174201 (Pubitemid 27231444)
35. [Effects of artesunate, pyronaridine and hydroxypiperaquine on chloroquine-sensitive and chloroquine-resistant isolates of Plasmodium falciparum in vitro](in Chinese). Li J, Huang WJ, Zhongguo Yao Li Xue Bao 1988 9 83 86 3055815 (Pubitemid 18012320)
36. In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum. Fu S, Bjorkman A, Wahlin B, Ofori-Adjei D, Ericsson O, Sjoqvist F, Br J Clin Pharmacol 1986 22 93 96 3527245 (Pubitemid 17177210)
37. In vitro sensitivity of multiresistant Plasmodium falciparum to new candidate antimalarial drugs in western Thailand. Schildbach S, Wernsdorfer WH, Suebsaeng L, Rooney W, Southeast Asian J Trop Med Public Health 1990 21 29 38 2205926
38. Uptake of 3[H] pyronaridine by Plasmodium falciparum infected erythrocytes in vitro. Elueze E, Croft SL, Warhurst DC, Cellular Pharmacology 1996 3 397 403
39. Chemosusceptibility analysis of Plasmodium falciparum imported malaria in Italy. Caramello P, Canta F, Cavecchia I, Sergi G, Balbiano R, Ariaudo S, Audagnotto S, Di Perri G, Diagn Microbiol Infect Dis 2005 52 107 112 10.1016/j.diagmicrobio.2005.01.002 15964498 (Pubitemid 40826936)
40. [Center of multidrug-resistant malaria in a forest zone of Cameroon revisited after 14years](in French). Agnamey P, Moyou SR, Brasseur P, Galega PF, Med Trop (Mars) 2002 62 141 144 (Pubitemid 36329408)
41. Positive relationship between the response of Plasmodium falciparum to chloroquine and pyronaridine. Warsame M, Wernsdorfer WH, Payne D, Bjorkman A, Trans R Soc Trop Med Hyg 1991 85 570 571 10.1016/0035-9203(91)90345-Y 1780977
42. The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin. Peters W, Robinson BL, Ann Trop Med Parasitol 1997 91 141 145 9307655 (Pubitemid 27174029)
43. [Effects of large doses of pyronaridine and chloroquine on the ultrastructure of the erythrocytic stages of pyronaridine-resistant line of Plasmodium berghei] (in Chinese). Wu LJ, Zhongguo Yao Li Xue Bao 1988 9 87 89 3055816
44. [Detection of 54-kDa protein overexpressed by chloroquine-resistant Plasmodium berghei ANKA strain in pyronaridine-resistant P berghei ANKA strain] (in Chinese). Li GD, Liu SQ, Ye XY, Qu FY, Zhongguo Yao Li Xue Bao 1995 16 17 20 7771189
45. [Determination of polyamines in pyronaridine-sensitive and -resistant Plasmodium berghei-infected erythrocytes] (in Chinese). Shi X, Ye X, Cai Y, Ha S, Yao J, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1998 16 109 112 12078217
46. [Delay in emergence of resistance to pyronaridine phosphate in Plasmodium berghei] (in Chinese). Shao BR, Ye XY, Zhongguo Yao Li Xue Bao 1986 7 463 467 2954424
47. Selection and reversal of Plasmodium berghei resistance in the mouse model following repeated high doses of artemether. Xiao SH, Yao JM, Utzinger J, Cai Y, Chollet J, Tanner M, Parasitol Res 2004 92 215 219 10.1007/s00436-003- 1029-9 14677058 (Pubitemid 38230473)
48. [Stability of drug resistance of a pyronaridine-resistant line of Plasmodium berghei] (in Chinese). Shao BR, Ye XY, Zheng H, Zhongguo Yao Li Xue Bao 1985 6 183 105 2943123
49. The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials. Peters W, Robinson BL, Ann Trop Med Parasitol 1992 86 455 465 1288426 (Pubitemid 23040785)
50. The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of drug resistance, Part 1: Which model is appropriate? Peters W, Ann Trop Med Parasitol 1999 93 569 587 10.1080/00034989958087 10707103 (Pubitemid 29438128)
51. The chemotherapy of rodent malaria. LVIII. Drug combinations to impede the selection of drug resistance, Part. 2: The new generation-artemisinin or artesunate with long-acting blood schizontocides. Peters W, Robinson BL, Ann Trop Med Parasitol 2000 94 23 35 10.1080/00034980057581 10723521 (Pubitemid 30110372)
52. [Longitudinal surveillance of sensitivity of Plasmodium falciparum to pyronaridine in south Yunnan] (in Chinese). Yang H, Liu D, Huang K, Zhang C, Li C, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1998 16 81 83 12078227
53. [In vitro sensitivity of Plasmodium falciparum to chloroquine, piperaquine, pyronaridine and artesunate in Yuxi prefecture of Yunnan province] (in Chinese). Fan B, Zhao W, Ma X, Huang Z, Wen Y, Yang J, Yang Z, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1998 16 460 462 12078295
54. [Sensitivity of Plasmodium falciparum to seven antimalarials in China-Laos border] (in Chinese). Yang H, Liu D, Dong Y, Yang P, Liu R, Zhang B, Zhang C, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1995 13 111 113 7554157
55. [Establishment of in vitro microtest for determining sensitivity of Plasmodium falciparum to pyronaridine] (in Chinese). Liu DQ, Feng XP, Liu RJ, Zhang CY, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2006 24 102 105 16862905
56. A 5-year surveillance of sensitivity in vivo of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in Diaoluo area, Hainan Province. Shao BR, Huang ZS, Shi XH, Meng F, Southeast Asian J Trop Med Public Health 1991 22 65 67 1822940
57. Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Looareesuwan S, Kyle DE, Viravan C, Vanijanonta S, Wilairatana P, Wernsdorfer WH, Am J Trop Med Hyg 1996 54 205 209 8619449 (Pubitemid 26084442)
58. [Tissue schizontocidal action and acute toxicity of trifluoroacetyl primaquine] (in Chinese). Ye XY, Shao BR, Zhongguo Yao Li Xue Bao 1990 11 359 362 2104491
59. [Combined action of pyronaridine and sulfadoxine/pyrimethamine against Plasmodium berghei ANKA strain in mice] (in Chinese). Shi XH, Shao BR, Ye XY, Zhongguo Yao Li Xue Bao 1990 11 66 69 2206014
60. Liu D, Sun J, Fu X, Zhang J, Wang Y, Ren D, Xu Y, Experimental observation on injection of new antimalarial '7351' Shanghai: Chinese Academy of Medical Sciences 1973 148 155
61. [On the residual activity of pyronaridine against Plasmodium cynomolgi in rhesus monkeys] (in Chinese). Zhang JX, Lin BY, Chen KY, Shao BR, Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1986 4 129 131 3769158
62. [Therapeutic effect of pyronaridine given intragastrically on Plasmodium cynomolgi-infected rhesus monkeys] (in Chinese). Chen KY, Shao BR, Zhang JX, Lin BY, Yao Xue Xue Bao 1985 20 309 311 4072704
63. [Experimental studies on chemotherapeutic effects and toxicities of a new antimalarial drug 7351 (author's transl)]. Institute of Parasitic Diseases Chinese Academy of Medical Sciences, Yao Xue Xue Bao 1980 15 630 632 6789612
64. Assessment of pyronaridine activity in vivo and in vitro against the hepatic stages of malaria in laboratory mice. Basco LK, Ringwald P, Franetich JF, Mazier D, Trans R Soc Trop Med Hyg 1999 93 651 652 10.1016/S0035-9203(99) 90085-8 10717758 (Pubitemid 30015797)
65. [Residual blood schizontocidal activity of pyronaridine against rodent malaria] (in Chinese). Shao BR, Ye XY, Zheng H, Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1984 2 232 233 242 6518633
66. Antimalarial and toxic effect of triple combination of pyronaridine, sulfadoxine and pyrimethamine. Shao BR, Huang ZS, Shi XH, Zhan CQ, Meng F, Ye XY, Huang J, Ha SH, Southeast Asian J Trop Med Public Health 1989 20 257 263 2692191
67. Comparison of effects of pyronaridine, amodiaquine, mefloquine and qinghaosu on rodent malaria. Shao BR, Ye XY, Chu YH, Southeast Asian J Trop Med Public Health 1992 23 59 63 1523480
68. Pyronaridine: an effective antimalarial against multidrug-resistant malaria. Dutta GP, Puri SK, Awasthi A, Mishra M, Tripathi R, Life Sci 2000 67 759 763 10.1016/S0024-3205(00)00670-6 10968405 (Pubitemid 30482744)
69. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice. Tripathi R, Umesh A, Mishra M, Puri SK, Dutta GP, Exp Parasitol 2000 94 190 193 10.1006/expr.1999.4470 10831384 (Pubitemid 30333399)
70. [7 antimalarials in the treatment of mice experimentally infected with pyronaridine-resistant Plasmodium berghei] (in Chinese). Chen KY, Lin BY, Zhang JX, Shao BR, Zhongguo Yao Li Xue Bao 1983 4 269 273 6230874 (Pubitemid 14176141)
71. Development of the new antimalarial drug pyronaridine: a review. Chen C, Zheng X, Biomed Environ Sci 1992 5 149 160 1642789
72. Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro. Chavalitshewinkoon-Petmitr P, Pongvilairat G, Auparakkitanon S, Wilairat P, Parasitol Int 2000 48 275 280 10.1016/S1383-5769(99)00028-8 10725690 (Pubitemid 30145444)
73. Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria. Ringwald P, Meche FS, Basco LK, Am J Trop Med Hyg 1999 61 446 448 10497988 (Pubitemid 29428718)
74. Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections. Ringwald P, Bickii J, Same-Ekobo A, Basco LK, Antimicrob Agents Chemother 1997 41 2317 2319 9333075 (Pubitemid 27422240)
75. Zheng X, Studies of new antimalarial '7351' Shanghai: Chinese Academy of Medical Sciences 1972 165 173 23082912
76. [The embryotoxicity of a new antimalarial pyronaridine in rats] (in Chinese). Ni YC, Zhan CQ, Ha SH, Shao BR, Yao Xue Xue Bao 1982 17 401 406 7148461
77. Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs. Naisbitt DJ, Williams DP, O'Neill PM, Maggs JL, Willock DJ, Pirmohamed M, Park BK, Chem Res Toxicol 1998 11 1586 1595 10.1021/tx980148k 9860505 (Pubitemid 29013636)
78. [Evaluation of the phototoxicity of five antimalarial agents and praziquantel in mice] (in Chinese). Shao BR, Zhan CQ, Ha SH, Zhongguo Yao Li Xue Bao 1986 7 273 275 2954378
79. Pyronaridine: A new antimalarial drug. Fu S, Xiao SH, Parasitol Today 1991 7 310 313 10.1016/0169-4758(91)90267-R 15463400 (Pubitemid 121007896)
80. Experimental studies on combinations of pyronaridine/primaquine versus chloroquine/primaquine. Shao BR, Zhan CQ, Chen KY, Ye XY, Lin BY, Ha SH, Zhang JX, Chin Med J (Engl) 1990 103 1024 1026
81. [Influence of pyronaridine phosphate on three-generation reproduction in rats] (in Chinese). Shao BR, Zhan CQ, Ha SH, Zhongguo Yao Li Xue Bao 1985 6 131 134 2934948 (Pubitemid 15070747)
82. Investigators, Brochure: Pyramax Tablets and Granules (Pyronaridine: artesunate) 2011
83. Mutagenicity of a new antimalarial drug, pyronaridine, in the Salmonella/microsome system (author's transl). Ni YC, Xu YQ, Shao BR, Zhongguo Yao Li Xue Bao 1982 3 51 55 6211906
84. [The mouse micronucleus test for mutagenicity of pyronaridine, chloroquine, quinacrine, primaquine, furapyrimidone and phenthiourezine] (in Chinese). Shao BR, Xu YQ, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1988 6 272 274 3253026
85. Zhan CQ, Ha SH, Shao BR, Chromosomal aberration test with pyronaridine, furapyrimidone and furazolidone Shanghai: 1986 1986 150 152
86. The non-induction of micronuclei by quinacrine. Maier P, Schmid W, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1975 30 299 301
87. An application of Acridine Orange fluorescent staining to the micronucleus test. Hayashi M, Sofuni T, Ishidate M, Mutation Research Letters 1983 120 241 247 10.1016/0165-7992(83)90096-9 (Pubitemid 13103085)
88. [Dominant lethal test with pyronaridine on male mice] (in Chinese). Shao BR, Zhan CQ, Ha SH, Ni YC, Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1983 1 121 123 6678650
89. Amodiaquine induced agranulocytosis and liver damage. Neftel KA, Woodtly W, Schmid M, Frick PG, Fehr J, Br Med J (Clin Res Ed) 1986 292 721 723 10.1136/bmj.292.6522.721 (Pubitemid 16167398)
90. In vitro and in vivo metabolism of pyronaridine characterized by low-energy collision-induced dissociation mass spectrometry with electrospray ionization. Lee J, Son J, Chung SJ, Lee ES, Kim DH, J Mass Spectrom 2004 39 1036 1043 10.1002/jms.663 15386754 (Pubitemid 39242974)
91. [Evaluation of the phototoxic effects of chloroquine and eleven other antimalarials in mice] (in Chinese). Yuan BJ, Li BC, Shen NC, Zhongguo Yao Li Xue Bao 1986 7 468 470 2954425
92. Development and validation of a liquid chromatography-mass spectrometry assay for the determination of pyronaridine in human urine. Naik H, Wei SY, Schmidt MS, Murry DJ, Fleckenstein L, J Chromatogr B Analyt Technol Biomed Life Sci 2007 853 80 87 10.1016/j.jchromb.2007.02.054 17409032 (Pubitemid 46891336)
93. [Pharmacokinetics of pyronaridine, an antimalarial in rabbits] (in Chinese). Feng Z, Jiang NX, Wang CY, Zhang W, Yao Xue Xue Bao 1986 21 801 805 3591314
94. Feng Z, Wang C, Studies on absorption distribution and excretion of '7351' by intramuscular injection Shanghai: Chinese Academy of Medical Sciences 1973 144 147 23054089
95. Determination of pyronaridine in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies. Jayaraman SD, Ismail S, Nair NK, Navaratnam V, J Chromatogr B Biomed Sci Appl 1997 690 253 257 10.1016/S0378-4347(96)00410-0 9106050 (Pubitemid 27136476)
96. Development and validation of a liquid chromatography-mass spectrometry assay for the determination of pyronaridine in human blood for application to clinical pharmacokinetic studies. Naik H, Imming P, Schmidt MS, Murry DJ, Fleckenstein L, J Pharm Biomed Anal 2007 45 112 119 10.1016/j.jpba.2007.06.018 17681448 (Pubitemid 47375003)
97. Analysis of blood and urine samples from Macaca mulata for pyronaridine by high-performance liquid chromatography with electrochemical detection. Wages SA, Patchen LC, Churchill FC, J Chromatogr 1990 527 115 126 2365769 (Pubitemid 20148217)
98. Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials. O'Neill PM, Mukhtar A, Stocks PA, Randle LE, Hindley S, Ward SA, Storr RC, Bickley JF, O'Neil IA, Maggs JL, Hughes RH, Winstanley PA, Bray PG, Park BK, J Med Chem 2003 46 4933 4945 10.1021/jm030796n 14584944 (Pubitemid 37352033)
99. [Distribution and excretion of 3H-pyronaridine in mice] (in Chinese). Feng Z, Wu ZF, Wang CY, Jiang AG, Yao Xue Xue Bao 1988 23 629 632 3254045
100. Absorption, distribution, excretion, and pharmacokinetics of 14C-pyronaridine tetraphosphate in male and female Sprague-Dawley rats. Park SH, Pradeep K, J Biomed Biotechnol 2010 2010 590707 20379367
101. Liquid chromatographic determination of pyronaridine in human plasma and oral dosage form. Babalola CP, Scriba GK, Sowunmi A, Alawode OA, J Chromatogr B Analyt Technol Biomed Life Sci 2003 795 265 272 10.1016/S1570-0232(03)00591-9 14522031 (Pubitemid 37186796)
102. [Pharmacokinetics of pyronaridine in malaria patients] (in Chinese). Feng Z, Wu ZF, Wang CY, Jiang NX, Zhongguo Yao Li Xue Bao 1987 8 543 546 3330403
103. Population pharmacokinetics of pyronaridine following oral pyronaridine/artesunate treatment in healthy and malaria infected subjects. Methaneethorn J, Duparc S, Borghini-Fuhrer I, Shin C, Jung D, Fleckenstein L, American Society of Tropical Medicine and Hygiene 60th Annual Meeting 2011 85 199
104. Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. Ramharter M, Kurth F, Schreier AC, Nemeth J, Glasenapp I, Belard S, Schlie M, Kammer J, Koumba PK, Cisse B, Mordmüller B, Lell B, Issifou S, Oeuvray C, Fleckenstein L, Kremsner PG, J Infect Dis 2008 198 911 919 10.1086/591096 18694333
105. [Therapeutic effect of pyronaridine in plain tablets and enteric-coated tablets in falciparum malaria patients] (in Chinese). Huang ZS, Feng Z, Meng F, Zeng LH, Lin X, Zheng Y, Xing QF, Guo RN, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1989 7 19 21 2670309
106. Treatment of 10 cases of chloroquine-resistant falciparum malaria with pyronaridine. Cai XZ, Pang XJ, Chen W, Chinese Journal of Parasitology and Parasitic Diseases 1987 5 228
107. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Ringwald P, Bickii J, Basco L, Lancet 1996 347 24 28 10.1016/S0140-6736(96)91558-5 8531545 (Pubitemid 26012413)
108. Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria. Basco LK, Ringwald P, Am J Trop Med Hyg 2000 63 215 221 11421367 (Pubitemid 32537553)
109. [Polychemoresistant Plasmodium falciparum malaria, successfully treated with a benzonaphthyridine](in French). Lapierre J, Nouv Presse Med 1982 11 673 7041087 (Pubitemid 12163101)
110. Drug resistant malaria, with special reference to Thailand. Looareesuwan S, Harinasuta T, Chongsuphajaisiddhi T, Southeast Asian J Trop Med Public Health 1992 23 621 634 1298068 (Pubitemid 23121535)
111. Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children. Ringwald P, Bickii J, Basco LK, Clin Infect Dis 1998 26 946 953 10.1086/513942 9564481 (Pubitemid 28180335)
112. [Combined use of pyronaridine, sulfadoxine and primaquine in areas with chloroquine-resistant falciparum malaria] (in Chinese). Che LG, Huang KG, Yang HL, Yu L, Lin ZL, Huang R, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1987 5 194 196 3329070
113. [Studies on the sensitivity of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in vitro] (in Chinese). Han XL, Liu DQ, Feng XP, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2000 18 8 10 12567461
114. [Effects of combined dose of pyronaridine/sulfadoxine/pyrimethamine on falciparum malaria] (in Chinese). Huang ZS, Shao BR, Meng F, Zeng LH, Ye XY, Huang J, Shi XH, Guo RN, Li X, Xing QF, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1988 6 285 288 3075524
115. Efficacy of combined use of pyronaridine, sulfadoxine and pyrimethamine in the treatment of falciparum malaria on Hainan Island. Pang XJ, Liu QJ, Chen QY, Cai XZ, Lin KH, Ou FZ, Liu YP, Fu SG, Liu XM, Liu HH, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1988 6 289 291 3075525
116. In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan. Yang H, Yang P, Yang Y, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1994 12 140 142 7955166
117. [Observation on the efficacy of combined use of some new antimalarials for the treatment of falciparum malaria in Hainan Province] (in Chinese). Chen L, Dai ZR, Qian YL, Ma ZM, Guo FC, Liao ZH, Fu DD, Ma DQ, Pang XJ, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1989 7 81 84 2680154
118. [Study on treatment of multi-drug resistant falciparum malaria by using a combination of dihydroartemisinin and pyronaridine] (in Chinese). Liu DQ, Lin SG, Feng XP, Chen WJ, Chen PL, Wu HM, Chen C, Liu J, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2002 20 193 196 12568014
119. Results of a randomised, multicentre, phase II, doseranging clinical study to assess the safety and efficacy of fixed dose, orally administered pyronaridine and artesunate in adult patients with acute uncomplicated Plasmodium falciparum malaria [Abstract 1004]. Krudsood S, Looareesuwan S, Gaye O, Tjitra E, Bojang K, Socheat D, Piola P, American Society of Tropical Medicine and Hygiene 56th Annual Meeting; 4-8 November; Philadelphia, PA, USA 2007 18062083
120. Duparc S, Borghini-Fuhrer I, Craft JC, Arbe-Barnes SJ, Miller RM, Schin C, Fleckenstein L, Efficacy of pyronaridine-artesunate in clincial trials in patients with uncomplicated acute Plasmodium falciparum or Plasmodium vivax malaria: results of an intergrated analysis [Abstract 300] Washington DC, USA: In Americian society of Tropical Medicine and Hygiene 58th Annual meeting 18-22 November 2009
121. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, Pyronaridine-artesunate Study Team, Lancet 2010 375 1457 1467 10.1016/S0140-6736(10)60322-4 20417857
122. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria. Rueangweerayut R, Phyo AP, Uthaisin C, Poravuth Y, Binh TQ, Tinto H, Penali LK, Valecha N, Tien NT, Abdulla S, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, Pyronaridine-Artesunate Study Team, N Engl J Med 2012 366 1298 1309 10.1056/NEJMoa1007125 22475593
123. The radical efficacy of pyronaridine-primaquine combination in tertian malaria. Huei BL, Shen SL, Wang KS, Gao SF, Cao SZ, Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1984 2 260 262 6394174
124. The efficacy of three therapeutic regimens in treating vivax malaria patients. Liu Y, Wan C, He J, Hu Y, Jia J, Jiang W, Lo M, Shi W, Chinese Journal of Parasitic Disease Control 1990 3 267 270
125. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial. Poravuth Y, Socheat D, Rueangweerayut R, Uthaisin C, Pyae Phyo A, Valecha N, Rao BH, Tjitra E, Purnama A, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, PLoS One 2011 6 14501 10.1371/journal.pone.0014501 21267072
126. Amodiaquine-induced hepatitis. A report of seven cases. Larrey D, Castot A, Pessayre D, Merigot P, Machayekhy JP, Feldmann G, Lenoir A, Rueff B, Benhamou JP, Ann Intern Med 1986 104 801 803 2871789 (Pubitemid 16115046)
127. Results of Central ECG review of two phase II Pyramax studies. Arbe-Barnes SJ, XVIIth International congress for Tropical Medicine and Malaria v 2008 58 Abstract # P434 Jeju Island Korea
128. Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Ribeiro IR, Olliaro P, Med Trop 1998 58 50 53 (Pubitemid 128707818)